Consumables > Culture media

Lonza Clonetics primary human diseased airway cells

11 October, 2010 by

Lonza has available a broad selection of cryopreserved primary human diseased airway cells including, bronchial epithelial, smooth muscle cells and lung fibroblasts from both COPD and asthmatic donors.


EpiGro epithelial cells and culture media

11 October, 2010 by

The range of EpiGro epithelial cells and culture media has been optimised to provide improved cell culture for critical research applications. The breakdown of control mechanisms in epithelial cells is a frequent contributor to cancer progression and metastasis.


Poietics ECFCs human endothelial colony forming cells

11 October, 2010 by

Poietics ECFCs human endothelial colony-forming cells are a unique population of highly proliferative cells isolated from human umbilical cord blood that demonstrate endothelial behaviour in culture.


Lonza Clonetics HSeC-Human Sertoli cells

11 October, 2010

Clonetics HSeC-Human Sertoli Cells are an asset to research involving male infertility and reproductive toxicology, xeno/allograft cotransplantation, immune suppression and many other applications.


B-ALI Bronchial Air Liquid Interface Media Kit, a guaranteed 3D in vitro model for respiratory research

10 October, 2010 by By Sorin Damian, George Klarmann and Marjorie Smithhisler, Lonza Walkersville, Inc

The Clonetics B-ALI Bronchial Air Liquid Interface Medium BulletKit provides a model system to investigate bronchial epithelial cells in a more physiologically relevant way.


Oxoid Brilliance Staph 24 Agar

07 October, 2010 by

Brilliance Staph 24 Agar is a selective and diagnostic chromogenic medium for the isolation and enumeration of coagulase-positive staphylococci (CPS) in foods, within 24 h.


Harvard Apparatus Artificial Cerebrospinal Fluid (CSF)

07 October, 2010 by

Harvard Apparatus Artificial Cerebrospinal Fluid (CSF) is claimed to closely match the electrolyte concentrations and osmolality found in authentic cerebrospinal fluid.


Sigma Life Science engineered mammalian cell lines

07 October, 2010 by

Sigma Life Science has released a range of engineered mammalian cell lines. The product range combines Sigma’s CompoZr zinc finger nuclease (ZFN) technology with the company’s experience in gene silencing to offer tools for drug discovery, compound screening and fundamental research applications.


Protocols for converting cells to serum-free culture

01 October, 2010

Instructions for use are provided in this article for protocols for converting cells to serum-free culture.


Lonza Australian-origin foetal bovine serum

03 September, 2010 by

Lonza’s Australian-origin foetal bovine serum can be used in cell culture media, production of biological/diagnostic products and other laboratory procedures.


CELLnTEC progenitor cell targeted culture media

04 August, 2010

Lomb Scientific is now the exclusive Australian and New Zealand distributor for CELLnTEC advanced cell systems. CELLnTEC specialises in the provision of novel progenitor cell targeted (PCT) culture media for epithelial cells, primary cells and media for 3D models.


Millipore ProRes-S media

04 August, 2010

With the addition of ProRes-S media, Millipore’s purification suite now provides a complete solution for the downstream purification of monoclonal antibodies and proteins. Developed jointly with The Dow Chemical Company, ProRes-S media offers biopharmaceutical manufacturers greater flexibility and increased throughput in a smaller manufacturing footprint.


Millipore ProRes-S media

03 August, 2010

With the addition of ProRes-S media, Millipore’s purification suite now provides a complete solution for the downstream purification of monoclonal antibodies and proteins. Developed jointly with The Dow Chemical Company, ProRes-S media offers biopharmaceutical manufacturers greater flexibility and increased throughput in a smaller manufacturing footprint.


Lonza Serum Supreme

02 August, 2010

Lonza produces a variety of sera products for use in cell culture media, production of biological and diagnostic products, and other laboratory procedures that require quality serum.


BioWhittaker X-VIVO media systems

02 August, 2010

Lonza’s R&D efforts and collaboration with many clinical trials have provided Lonza with the tools and expertise to support the developments in adoptive immunotherapy, cancer therapy, genetic therapy and other cellular therapies.


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd